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Lymphocytes from many species have been classified into T  and B cells according 
to their differentiation pathways and specialized immune functions. They are distin- 
guishable phenotypically by characteristic molecules that are expressed on their cell 
surfaces  (1).  In  man,  Ia-like antigens,  surface  immunoglobulins,  and  complement 
receptors  are  expressed  preferentially  on  B  lymphocytes, whereas  the  receptor  for 
sheep erythrocytes is a general marker for T  lymphocytes. Using serological methods, 
subpopulations of human B and T  cells have been found recently (2-6). Efforts have 
begun in a number of laboratories towards the biochemical characterization of specific 
lymphocyte-surface components  (7-9)  and  the  development  of serological reagents 
toward these marker proteins. 
In the present study, the identification of molecules, expressed preferentially on the 
cell surface of cultured  human B cells and on normal lymphoid tissue, was initially 
studied through the use of a  B-cell-specific rabbit antiserum.  In addition to reacting 
with Ia-like antigens  in immunoprecipitation experiments, this absorbed anti-B-ceU 
serum reacted with several other major surface glycoproteins with mol wt of 54,000, 
86,000, and 105,000. These glycoproteins were purified from the B-lymphoid cell line, 
B35M,  and  attempts were made to raise rabbit  antisera  towards  each component. 
This  paper  describes  the  purification  and immunological  characterization  of the 
54,000  dalton  antigen  which  proved  most  amenable  to  isolation  and  study.  Its 
expression on cultured human cell lines, normal lymphocytes, as well as various types 
of leukemic cells, was determined. The effect of anti-gp54 serum on DNA synthesis of 
lymphocytes was also investigated. 
Materials and Methods 
Cell Preparation.  Mononuclear cells were isolated from normal or leukemic peripheral blood 
by discontinuous  Ficoll-Hypaque gradients  (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway, N. J.).  Mononuclear cells were obtained from tonsillar tissues as described 
previously (10). Monocytes were removed by a carbonyl iron-ingestion  method. Preparations of 
enriched T- and B-lymphocyte populations were made by Ficoll-Hypaque gradient separation 
of lymphocytes rosetted with neuraminidase-treated sheep erythrocytes. 
The following cultured human cell lines were utilized which had been derived from Burkitt's 
iymphomas: Daudi, B35M,  and Raji; from leukemic patients: RPMI 8866, K562, Jurkat, SB, 
and HSB; or from normal peripheral blood lymphocytes, RPMI 1788. They were maintained 
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in  medium  RPMI-1640  (Microbiological Associates, Walkersville, Md.), supplemented with 
10% fetal calf serum.  17 B-lymphoblastoid cell lines derived from one tonsil and other cell lines 
from normal donors were initiated and maintained as previously described (11). 
Preparation  of Antisera.  New  Zealand  white  rabbits,  selected  for  the  absence  of natural 
antibodies to lymphocytes, were used  for immunization.  All the antigen  preparations were 
emulsified with complete Freund's adjuvant, injected intradermally at multiple sites on  the 
back, and followed by four to eight injections given in a similar way, 2 wk apart. 
(a)  A rabbit anti-human B-lymphocyte serum was raised by repeatedly immunizing a rabbit 
with 500 #g of glycoprotein fraction of B cell-line plasma membranes (B35M) isolated from a 
concanavalin A  (Con A)Laffinity column. 
(b)  Rabbit anti-human Ia serum was prepared by immunizing a rabbit with 25 #g/injection 
of a 65,000 dalton gp28, 37 Ia bimolecular complex isolated from a B-lymphoblastoid cell line, 
B35M, as described previously (12,  13). 
(c)  Rabbit anti-gp54 serum was produced by immunizing rabbits with 25-50 #g/injection 
ofa 54,000-dahon component isolated from the B cell line, B35M (material identical to that in 
gel b of Fig. 3). 
A  rabbit  anti-HLA heavy-chain serum  was  a  generous gift from  Dr.  R.  E.  Humphreys, 
University of Massachusettes Medical Center, Worcester, Mass. It was found to have broad 
HLA reactivity when tested by immunoprecipitation assay on various peripheral blood lym- 
phocyte, leukemias, and tonsil cells. Rabbit antiserum made against Fab fragments of human 
FrI! IgG and sheep antiserum made against F(ab')2 fragments of rabbit immunoglobulin, were 
produced in similar ways. All sera were heat inactivated at 56°C for 45 min before use. 
Surface  Immunofluorescence.  F(ab')z  fragments,  from  all  the  antisera,  were  prepared  and 
conjugated with tetramethylrhodamine isothiocyanate as previously reported (14).  The trace 
Fc-containing molecules were removed by absorbing the reagents with protein-A Sepharose 
CL-4B beads (Pharmacia Fine Chemicals, Div. of Pharmacia Inc.). The sheep anti-F(ab')2 of 
rabbit IgG reagent was absorbed with human Fr.II-Sepharose  4B beads and human erythrocytes 
before use. The cell-surface antigens were detected by direct immunofluorescence as described 
before (14).  Usually, in the case of gp54 antigen, a second reagent, sheep anti-F(ab')2 of rabbit 
IgG, was used to intensify the staining. Monocytes were identified by their capacity to ingest 
latex particles. 
SlCr-Release  Complement-Mediated  Cytotoxicity  Assays.  The  51Cr-release  cytotoxicity assay of 
antisera and the cytotoxicity inhibition assay for antigen was performed in triplicate according 
to established techniques (15). 
Target cells incubated in medium alone, without added complement and antibodies, were 
included in each experiment to determine the percentage of spontaneous 51Cr-release.  Target 
cell aliquots were lysed with 0.5% Nonidet P-40 (NP-40) detergent solution for determination 
of the maximum percentage of releasable 5~Cr. Percentage of cytotoxicity was calculated using 
the following formula: 
Experimental % 51Cr release -  % spontaneous SlCr release 
% Cytotoxicity --  Maximal % S~Cr release -  % spontaneous 51Cr release  ×  100. 
Quasntitative Absorption Analysis.  Suspensions containing variable amounts of cells (0.08-250 
×  10/50 #1) were added to equal volumes of the heat-inactivated antiserum and incubated at 
room  temperature  for  1 h  with constant  shaking.  Cells were removed by centrifugation at 
15,000 rpm for 3 min, and the remaining reactivity of the antiserum was tested by complement- 
mediated cytotoxicity and  by immunoprecipitation analysis. For Ia-antigen quantitation,  a 
1:50 dilution of the serum was used for absorption and for gp54 antigen quantitation, a  1:10 
dilution of the serum was used. 
lodination  of Cells.  A  modification of the method  of Marchalonis et  al.  (16)  was used to 
iodinate the cell surface. Cells from various cell lines were harvested and washed three times in 
phosphate-buffered saline  (PBS)  (pH  7.4);  the  viability was  measured  by  trypan  blue dye 
exclusion and usually was >95%. To 2 ml of cell suspension (1  ×  107/ml), 0.5 mCi Na 12sI and 
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200 #g lactoperoxidase, purified as described,  (17) were added,  followed  by 25 #l of freshly 
prepared 0.03% H202 at 5-rain intervals.  The reaction was terminated by the addition of cold 
phosphate-buffered saline (PBS). The cells were washed and lysed with 0.5% NP-40 solution at 
a  concentration  of  1  ×  l0  T cells/ml.  The  lysate was  dialyzed  extensively before  further 
processing. 
Immunoprecipitation.  For immunoprecipitation experiments, 50/zl of rabbit antiserum known 
to be in excess was incubated with  100 #1 of a  10% (wt/vol) solution of protein-A Sepharose 
CL-4B beads at 37°C  for 30 rain. The washed antibody-coated immunoabsorbent was then 
incubated with  an aliquot  of the radiolabeled  cell  lysate at  37°C  for another 30  rain  and 
followed  by three  washes  in  PBS  containing  0.1% NP-40.  The bound  x2nI-iabeled surface 
antigens were eluted by boiling the beads with 4 M urea and 2% sodium dodecyl sulfate (SDS) 
in 0.1  M Tris H(21 (pH 8.0) buffer, and followed by SDS-polyaerylamide gel eleetrophoresis. 
SDS-Polyac~ylamide Gel Electrophoresis.  The discontinuous  Tris-glycine system of Laemmli 
(18) was used for both slab gels and cylindrical gels. Unless especially mentioned, all the gels 
were electrophoresed under nonreducing conditions.  After electrophoresis,  gels were stained 
with  Coomassie Brilliant  Blue  or  periodic  acid-Schiff (PAS)  reagent  (20). In  the  case  of 
immunoprecipitation experiments, the  gels were dried  onto filter paper under  vacuum for 
subsequent autoradiography on (2hrondex x-ray film (DuPont Instruments, Wilmington, Del.). 
Apparent molecular weights were determined by the method of Weber and Osborn (19) with 
the following protein standards: human IgG myeloma protein (150,000 daltons), bovine serum 
albumin (68,000 daltons), ovalbumin (44,000 daltons), a-chymotrypsinogen (25,000 daltons), 
and cytoehrome (2 (11,000 daltons). 
For antigen isolation,  guide strips (1-cm wide) of the preparative slab gel were cut from both 
edges and stained with (2oomassie Brilliant  Blue. The areas having the antigens were cut from 
the unstained portion of the gel, and eluted with PBS (pH 7.4) overnight at 37°(2. 
Results 
Serological and Biochemical Analysis of Cell-Surface Components of Human B-Lymphoblastoid 
Cell Lines.  A B-cell antiserum was raised by immunizing a rabbit with glycoproteins 
isolated by Con A-affinity column chromatography from a B-lymphoblastoid cell line 
(B35M). This antiserum, after absorption with pooled T  cell lines, reacted specifically 
with isolated peripheral and tonsillar B cells. The surface components, recognized by 
the primary B-cell antiserum, were identified by immunoprecipitation of the surface 
radioiodinated B35M cell lysate as illustrated in Fig.  1. At least  10 components with 
molecular weights ranging from  15,000  to  150,000  were precipitated  by this serum 
(Fig.  1 a).  In  contrast,  rabbit  anti-actin  serum  (Fig.  1 b)  did  not  precipitate  any 
discernible component, and thus served as a control indicating the external nature of 
the iodinated membrane proteins. 
To analyze further these surface membrane components, large quantities of plasma 
membrane from a B cell line, B35M, were prepared, solubilized by sodium deoxycho- 
late and chromatographed on a Ultrogel AcA 34 (LKB Instruments Inc., Hicksville, 
N. Y.) column (2.5  ×  40 cm) as described before (15). Fig. 2 illustrates a representative 
gel-filtration  chromatogram  and  SDS-gel  electrophoresis  profile  of such  detergent 
solubilized B-cell membranes. The major proportion of the membrane components 
elute in the void volume and they were not studied further. Characterization of every 
third subsequent fraction by SDS-polyacrylamide gel electrophoresis demonstrated a 
series of polypeptides. The principal proteins had apparent mol wt of 105,000, 86,000, 
54,000,  37,000,  and  28,000,  as  indicated.  All  five  components  gave  positive  PAS 
staining which suggested their glycoprotein nature. 
By cytotoxicity inhibition and immunoprecipitation assays, the Ia aUoantigens were 
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Fro.  1.  Autoradiographs  of SDS gels of immunoprecipitates  prepared from Nonidet-P40  lysate  of 
a B-lymphoid  cell line, B35M. The rabbit antisera used were (a) anti-B-cell  glycoprotein  serum (b) 
anti-actin serum. 
with elution volumes slightly larger than that of IgG, and as a  bimolecular complex 
with  subunit  mol  wt  of 37,000  and  28,000  as  described  (12,  13,  21).  They were 
precipitated and identified by the anti-B-cell serum as components 9 and 10 shown in 
Fig.  1 a. The classical HLA antigens were eluted in the same column fractions as the 
Ia antigens in parallel cell membrane preparations, although in the case of B35M cell 
line, these antigens were present at relatively low concentrations. In fractions 34 to 46, 
two polypeptides with mol wt of 86,000 and  105,000 were identified by immunopre- 
cipitation as  components 4  and  5  of Fig.  1 a.  In  fractions 43  to 52,  another major 
protein with approximate mol wt of 54,000 was identified by immunoprecipitation as 
component 8 of Fig.  1 a which is the subject of the present study. For convenience, it 
will be referred as gp54 antigen. 
Isolation  of gp54  Antigen.  The  isolation  of  the  gp54  antigen  involved  plasma 
membrane preparations of B35M cell lines and solubilization in sodium deoxycholate, 
followed by  gel  filtration on  a  Ultrogel  34  column  as  described  above.  The  gp54 
antigen-enriched column fractions (43-49) were pooled, concentrated, and the mem- 
brane proteins were then separated by preparative SDS-polyacrylamide gel electro- 
phoresis (PAGE) as described in Methods. The gp54 antigen was eluted from the gel 
and re-electrophoresed on a 9% slab gel along with the detergent solubilized membrane 
preparation as shown in Fig. 3. The isolated gp54 antigen electrophoresed as a single 
component under both reduced and nonreduced conditions. 
Characterization of Antiserum to the gp54 Antigen.  By immunoprecipitation and SDS- 
PAGE analysis, the gp54 antiserum recognized only one protein component with a 
tool wt of 54,000. This is shown for one representative cell line ('r51) using the whole 
NP-40 solubilized lysate of cells iodinated with nsI (Fig. 4). This reaction is specific, 
because preimmune serum does not precipitate any protein components in the whole 
cell lysate. For comparison, immunoprecipitation of the anti-Ia serum and anti-HLA 1428  HUMAN  B-LYMPHOCYTE-SURFACE  ANTIGEN 
Fro.  2.  The  filtration  profile  from  a  preparative  Ultrogel  AcA  34  column  of the  detergent- 
solubilized  B35M  cell-line  membrane  macromolecules  (upper  portion).  The  molecular  weight 
markers used for calibration of the column were Dextran blue, IgG, and DNP-glycine, as indicated 
by  arrows  from  left  to  right.  The  Iit-alloantigenic  activity  was  detected  by  the  inhibition  of 
cytotoxicity assay  (dashed line curve).  Every third column fraction was subjected to SDS-PAGE 
(10%)  analysis  under  nonreduced  condition  and  stained  with  Coomassie  Brilliant  Blue  (lower 
portion). The fractions with peak Ia activity showed heavy protein bands at  tool wt 28,000  and 
37,000.  In fractions 43 to 52, the protein band ofmol wt 54,000 is evident as a dominant component. 
heavy-chain serum were also analyzed on the same gel. The anti-Ia serum precipitated 
the typical bimolecular complex with two subunits of tool wt of 28,000 and 37,000. 
The anti-HLA serum  precipitated the 48,000 heavy chain which  is associated with 
~2-microglobulin (Figs.  4 c and d). The gel was analyzed under nonreduced condition 
to  separate  the  HLA  heavy-chain  molecule  from  the  gp54  antigen  because  they 
comigrate at  an apparent tool wt of 45,000 in the presence of reducing agent.  The 
anti-gp54 serum  reacted in  a  similar manner with  NP-40 solubilized lysate of cells 
metabolically labeled with [3H]leucine. 
Expression of gp54 Antigen on  Various Human Lymphoid Lines.  Representative results 
by cytotoxicity titration of cell lines of B or T  origin with anti-gp54 serum are shown 
in Fig. 5. Lysis of the lines occurred in a plateau fashion with the percentage cell lysis C. Y. WANG, S.  M.  FU, AND H. G. KUNKEL  1429 
FIG. 3.  SDS-PAGE  pattern of  the isolated  gp54 glycoproteinCo).  For comparison,  the whole  plasma 
membrane preparation solubilized  by 0.5% sodium deoxycholate  is shown (a). The position of three 
marker proteins is indicated on the right. 
ranging between 5 and 90%. There is a preferential reactivity of the anti-gp54 serum 
towards  certain  B  cell  lines.  In  comparison,  the  anti-Ia  serum  gave close to  100% 
cytotoxicity against all B cell lines with the exception of the line 616, a  T51  variant 
(22).  The  results  of fluorescent  antibody  analyses  for  the  gp54  antigen  revealed 
parallel results to the cytotoxicity assay. The surface immunofluorescent staining of 
gp54 antigen has a  characteristic speckled and patchy pattern as shown in Fig. 6. A 
substantial cell to cell variation in the staining intensity was found in the lines having 
a high percentage of positive cells. To determine the nature of the restricted reactivity 
of the anti-gp54 serum, 17 cell lines were derived by Epstein-Barr virus transformation 
of the tonsillar B cells from one individual. Cells from each line were examined for 
the expression of three surface markers (gp54, smIg, and Ia antigens). The results of 
immunofluorescent studies are shown in Fig. 7. Nearly 100% of the cells in all 17 lines 
expressed Ia antigens. However, the expression of surface immunoglobulins and gp54 
antigens among the cell lines showed extreme heterogeneity and no correlation was 
found between the two markers. 
Quantitative Absorption Analyses.  Although the T  cell lines studied were negative for 
the gp54  antigen by both direct cytotoxicity and  immunofluorescent analyses, evi- 
dence was obtained by immunoprecipitation of the surface radioiodinated T  cell-line 
lysate and in absorption experiments for low level expression of the gp54 antigen on 
these cell lines. In the immunoprecipitation experiments, a relatively small band was 
usually obtained from the radiolabeled T  cell line as shown in Fig. 8. The quantitative 
difference of the  gp54  antigen  expression  on  the  B  and  T  cell  lines  was  further 
determined by absorption experiments. Two positive B-cell lines  (B35M  and 8866) 
and  the  two  T  cell  lines  (,Jurkat  and  1301)  were  chosen  for absorption  test.  The 
residual  antibody  activity in  the  absorbed  serum  was  tested  by both  complement 
dependent cytotoxicity and  immunoprecipitation assays on a  B  cell line, T51. The 
50% absorption endpoints for the two positive B cell lines and the negative T  cell lines 1430  HUMAN B-LYMPHOCYTE-SURFACE ANTIGEN 
FIo. 4.  Autoradiographs of SDS gels of immunoprecipitates prepared from Nonidet P-40 lysates 
of a surface-radioiodinated B-lymphoid  cell line, T51. The rabbit antisera used were: (a) anti-gp54 
serum; (b) preimmune control serum; (c) anti-Ia serum; (d) anti-HLA serum (heavy  chain). 
were: 0.4  X  105 cells/5 #1 serum and 50  X  105 cells/5 #1 serum, respectively, which 
indicates that the two positive B cell lines have ~ 125-fold more gp54 antigen expressed 
on the surface than the two negative T  cell lines. As for Ia antigens, similar absorption 
tests indicated that B cell lines expressed 500 times more than the T  cell lines did. 
After extensive absorption with pooled B cells, the anti-gp54 serum completely lost 
its lytic activity.  However, it  still  possessed up  to  20% of the original  precipitating 
activity as determined  by the  densitometer scan of the  gp54 band  in  the  autoradi- 
ogram. This suggests that some antibody activities were directed towards the buried 
determinants of the  gp54  antigen  although  other explanations  for these differences 
are present. 
Expression of  gp54 Antigens on TonsiUar  and Normal Peripheral Blood B Lymphocytes.  The 
reactivity of the anti-gp54 serum was assayed in the complement dependent cytotox- 
icity system.  In  a  typical  experiment,  the  antiserum  lysed 40%  of the  unseparated 
tonsillar mononuclear cells and 60% of the cells in the tonsillar B  layer at a  dilution 
of 1:50.  Similar results were obtained with less diluted serum. In the case of T  cells, 
no discernible cytotoxicity was observed even when  the  undiluted  anti-gp54 serum 
was used.  An anti-Ia serum however reacted with  60% of the unseparated cells and 
close to  100%  of the isolated  B  cells with  no appreciable reactivity towards T  cells. 
When  peripheral  blood  lymphocytes were  tested,  a  broad  spectrum  of reactivities 
towards the isolated B-cell preparations were observed with the anti-gp54 serum.  It 
varied  from <5%  to  50%  according  to  the  individual  studied.  On  the  contrary,  a 
consistent high percentage of lysis was detected in every B-cell preparation with the 
anti-Ia serum. Both antisera showed minimum reactivities towards the T-cell prepa- 
rations. Surface immunofluorescent studies revealed a similar reaction pattern to that 
shown by cytotoxicity as indicated in Table I and Fig. 6. There is again a considerable 
divergence in the number of cells expressing gp54 antigens in the peripheral blood B- 
cell preparations. Using Ia antigen  as a  general marker for B lymphocytes, the gp54 
antigen  defines  a  subpopulation  of  cells  residing  in  the  B-lymphocyte-enriched 
preparations. 
Expression of  gp54 Antigen on Cells  from Various Types of Leukemias.  Surface expression 
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F[o.  5.  Lysis  by complement-dependent cytotoxicity of various cultured cell lines  with anti-gp54 
serum. Cell lines used were B type: B35M(A), 8866(I),  T51(O), Raji(~, MG4(O), 1788(1~), T 
type: 1301(A),  Jurkat(~7), and the nonlymphoid line K562(O). 
nofluorescence. The various leukemias were classified into T-, B-, and non-B-, non-T 
lymphocytic types according to their surface expression of membrane immunoglobu- 
lins or the presence of receptors for the sheep erythrocytes. The expression of gp54 
antigen on leukemias of the non-B-, non-T lymphocyte type (e.g.  acute lymphatic, 
acute myelogenous, acute myelomonocytic, chronic myelogenous and erythroid leu- 
kemias) was not detectable, although in the majority of these cases Ia antigens were 
detected. Furthermore, in two of these cases, the leukemic cells were radioiodinated 
and no discernible component was brought down by the anti-gp54 serum in immu- 
noprecipitation experiments. The expression was also absent on the leukemias of the 
T-lymphocytic type. The leukemic cells of certain cases of B-type chronic lymphatic 
leukemias, although  100% positive with the Ia system, were completely negative for 
the  gp54  antigen.  Other  cases  showed  a  high  percentage  of gp54  positive  cells; 
however, the percentage of positive cells varied to a  great  degree. There was also a 
moderate degree of variability in intensity of staining from cell to cell. The expression 
of gp54 antigen on certain cells and not on others of the leukemic population in these 
cases emphasizes the heterogeneous nature of these leukemic cells. 
Activation of Human B Lymphocytes by Anti-gp54.  The effect of the anti-gp54 serum 
on DNA synthesis of human  lymphocytes obtained from either peripheral blood or 
tonsils  was  investigated.  As  controls,  the  preimmune  serum  as  well  as  the  anti-Ia 
serum were used in similar concentrations. The whole anti-gp54 serum as well as its 
IgG fraction, but not anti-Ia, were mitogenic for B lymphocytes from both sources. 
This stimulatory effect was further found to be T-cell independent and peak responses 
were obtained in cultures incubated for 4 d. Divalent and monovalent fragments of 
gp54 antibodies were prepared and assayed for their stimulatory potential. The results 
in  Fig.  9  show  that  only the  F(ab')2  fragments  can  cause  the  B-cell  proliferative 
response. These results strongly suggest that the activation of B lymphocytes obtained 
with  the  anti-gp54  serum  is  probably a  result  of the binding  of antibodies  to the 1432  HUMAN B-LYMPHOCYTE-SURFACE ANTIGEN 
FIo.  6.  Fluorescent  antibody  analysis  of B-lymphoid cell line and  tonsillar  lymphocytes using 
F(ab')2 fragments of antibodies raised  to the gp54 antigens.  (a), (c) are phase-contrast  micrographs 
of (b)  and  (d). (b)  Cells  from B-lymphoid cell line(Daudi) showing speckled  fluorescent  staining 
cells as well as patchy staining cells. (d) Fluorescent  micrograph of a B-cell-enriched  preparation of 
tonsillar lymphocytes showing bright staining cells. 
gp54 antigen on the cell surface via the antigen-binding sites and requires crosslinking 
of the surface antigens. Repeated attempts to induce immunoglobulin synthesis by 
the activated B cells were unsuccessful. However, preliminary results indicated that 
the  monovalent  Fab  fragments  of the  anti-gp54  reagent  markedly  inhibited  the 
formation of antibody-forming cells in a T-cell-dependent B-cell differentiation system 
(10). 
Discussion 
As a  result of serological and biochemical analysis of cell-surface components of 
human B-lymphoblastoid cell lines, a major cell-surface protein with an approximate 
mol wt of 54,000  was identified and isolated. The biochemical and immunological 
characterization of this component indicated that this antigen is a membrane glyco- 
protein exposed on the outer surface of the cell and not associated with fi2-microglob- 
ulin. 
This 54,000 dalton component, termed gp54, is immunochemically different from 
other structurally known surface components such as the HLA antigens which are 
associated  with  fi2-microglobulin,  the  surface  immunoglobulins  of IgM  and  IgD 
classes,  and the recently described I-region associated Ia antigens. By complement- 
dependent cytotoxicity, surface immunofluorescence, and radioimmunoprecipitation 
assays, this gp54 antigen was shown to be present on the Daudi cell line, a  cell line 
which does not express either HLA or fl2-microglobulin (23).  Also, the 616 cell line, 
an  Ia-negative  variant  of  the  T51  cell  line  which  was  isolated  by  cytotoxicity C.  Y. WANG, S.  M.  FU, AND H. G. KUNKEL 
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FIG. 7.  Antigen  expression on 17 lymphoid cell lines derived from the same individual determined 
by fluorescent antibody analysis using F(ab')2 fragments of antibodies raised to (a) gp54 antigens, 
(b) Fab fragment of human IgG, (c) Ia antigens. Each point represents one study on one cell line. 
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immunoselection  using  anti-Ia serum  and  complement  (22),  expresses the  antigen. 
However,  in  gel  electrophoresis  under  reducing  conditions,  it  is  rather  difficult  to 
recognize this component as a distinct molecule from HLA heavy chain, because they 
comigrate at similar apparent molecular weights between 45,000 and 50,000.  Surface 
membrane components with approximate molecular weights of 45,000 as analyzed by 
immunoprecipitation  and  SDS-PAGE  under  reducing  conditions  are  well  known. 
The antisera used in these studies appeared to be highly specific and various control 
and  preimmune rabbit  sera  did  not  precipitate  this  gp54  component.  However,  a 
number of human sera brought down a component of similar molecular weight from 
the B  cell lines.  It appears that  these sera may contain  specific antibodies.  Further 
studies with these human sera are currently underway. 
In the mouse, several gene products of chromosome 17 have been reported to have 
subunits  with  heavy chains  having  mol  wt  of 45,000  and  are  associated  with  fl2- 
microglobulins (24). These antigens include H-2D, H-2K, and TL. More recently, in 
the  mouse,  another  alloantigen  Lyb-2  has  been  reported  (25)  which  is  expressed 
exclusively  on  B  cells,  specified  by  a  locus  on  chromosome  4,  and  also  has  an 
approximate mol wt of 45,000 yet it is not associated with fl2-microglobulin subunit. 
In man, other than HLA antigens, there has been no definitive report regarding the 
identification  of any  of the  above mentioned  analogues.  Whether  the  antigen  we 
characterized here is a  Lyb-2-1ike molecule, remains to be determined.  In an earlier 
report,  a  component  with  a  mol  wt  of 50,000  was  noted  on  human  B  cells  by 
Trowbridge  and  his  coworkers  (7).  This  component  was  not  associated  with  fl2- 
microglobulin and may be the same as the gp54 antigen of the present report. 
More than 50 established human hematopoietic cell lines ha;ce been tested for their 
surface expression of gp54 antigen. Extreme heterogeneity with respect to expression 
was found both among lines and within  a  given line.  The differential expression of 
this antigen by different cell lines may reflect different stages of differentiation and 
maturation of the precursor cells. The quantitative difference of gp54 antigen on cell 
lines was clearly evident in absorption tests. The gp54 antigen is expressed 100-fold or 
more in the most positive B cell lines than on the negative B or T  cell lines. The gp54 
negative cell lines actually express the antigen at a density too low to be detected by 
immunofluorescence  and  cytotoxicity assays.  A  small  amount  of the  gp54  antigen 1434  HUMAN  B-LYMPHOCYTE-SURFACE  ANTIGEN 
TABLE  I 
Immunofluorescent Analysis of Cells Bearing la Antigens, Surface Immunoglobulins, 
and gp54 Antigen in E-RFC* Depleted or Enriched Cell Fractions 
Percentage of Positive Lymphocytes 
E-RFC depleted  E-RFC enriched 
Ia  smIg  gp54  Ia  smIg  gp54 
PBL  1  78  55  5  2  <1  <1 
PBL 2  48  28  18  6  <t  <1 
PBL 3  60  37  51  5  <1  <1 
Tonsil 1  95  60  78  7  <1  <1 
Tonsil 2  96  78  88  2  < 1  < 1 
Tonsil 3  93  72  57  3  <1  <1 
* Sheep erythrocyte rosette-forming cells are abbreviated as E-RFC. 
could in certain cases be revealed by radioimmunoprecipitation assay even in the T 
cell lines. Whether the accessibility or conformation of the gp54 antigen at the cell 
surface is  a  result  of its  glycosylation as  in  the case of T25  antigen  expression on 
certain mouse T-lymphoma cells (26) and the case of glucose-regulated protein on the 
fibroblast cells  (27), or as  a  "differentiation antigen" which  is  expressed in  varied 
amounts according to the cellular differentiation stages remains to be answered. 
Aside  from cultured cell lines,  lymphoid cells from peripheral blood and  tonsils 
were also examined for gp54 expression. Anti-gp54 serum identified a subset of human 
B lymphocytes from both sources which was shown by surface immunofluorescence 
and cytotoxicity assays. However, tonsil B lymphocytes have much higher reactivities 
than those of peripheral blood. This phenomenon could reflect differences in degree 
of maturation between cells in the blood stream and in the tonsil. Expression of gp54 
antigen  on  various  mitogen  stimulated  cultured  lymphocytes  is  currently  under 
investigation. 
Among the nonlymphoid cell types studied, this antigen was absent on erythrocytes, 
platelets, cultured normal fibroblast cells, and nonlymphoid leukemias. However, its 
presence on certain malignant melanoma cell lines and various carcinoma cell lines 
was found. 
In chronic lymphatic leukemias of the B-cell types, the gp54 antigen was present on 
the leukemic cells of only some of the cases. In the positive cases, the staining intensity 
and the percentage of stained cells varied greatly. This heterogeneity was very similar 
to  that  found  in  the  peripheral  blood  B  lymphocytes  and  tonsillar  B  cells.  The 
question  whether  this  antigen  will  prove  useful  in  classifying  chronic  lymphatic 
leukemia remains to be determined. 
The function of the gp54 antigen is not clear. Data were presented showing that 
F(ab')~ fragments of the anti-gp54 serum were stimulatory when they were added to 
either peripheral blood B cells or tonsillar B cells in vitro. Parallel studies with anti-Ia 
serum were completely negative. Preliminary results also indicate that the monovalent 
Fab  fragments  of the  anti-gp54  reagent  markedly  inhibit  the  activation  of B-cell 
differentiation to  plasma  cells  in  a  T-cell-dependent  B-cell  differentiation system. 
These data suggest that the gp54 antigen may in some way relate to the control of B- 
cell proliferation and differentiation. (3.  Y.  WANG,  S.  M.  FU,  AND  H.  G.  KUNKEL 
b 
FIc.  8.  Densitometer scanning patterns ofcomparatlve immunopreeipitates prepared from NP-40 
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FIG. 9.  Stimulation  of [aH]thymidine uptake by cultures of isolated human tonsillar B lymphocytcs 
with purified F(ab')2 fragments (0) and Fab fragments (O) of anti-gp54 serum. The control culture 
with F(ab')2 fragments of preimmune serum is also shown (A). 
Summary 
A major membrane glycoprotein with mol wt of approximately 54,000 has been 
isolated  from  membrane  preparations  of B-type  lymphoid  cell  lines.  Antiserum 
prepared against the isolated material specifically precipitated this glycoprotein from 
membranes labeled by surface radioiodination or by metabolic labeling. 
This antiserum was shown by complement-mediated cytotoxicity  assay, membrane 
immunofluorescent staining, and by quantitative absorption analysis to react prefer- 
entially with certain B-lymphoblastoid cell lines, with a minor population of periph- 
eral blood B lymphocytes, and a major population of tonsillar B lymphocytes. Certain 
B-cell leukemias also  expressed  the antigen, whereas others did not. Considerable 
variability was observed among positive B cells in the intensity of fluorescent staining 
even among the leukemic cells from a single individual. Although T cells, including 
T  cell  lines,  were  negative  by  direct  immunofluorescent and  cytotoxicity assay, 
evidence for low levels of the antigen on the cells of T cell lines was obtained. 
The whole specific antiserum and its F(ab')2  fragments stimulated B lymphocytes 
to proliferate. This proliferation did not produce differentiation to plasma cells and 
was T-cell independent. The monovalent Fab fragments had no effect. None of these 
preparations stimulated T  cells. The possibility that this antigen, termed gp54, may 
play some role in B-cell activation is discussed. 1436  HUMAN B-LYMPHOCYTE-SURFACE  ANTIGEN 
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